Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110551771B details a green enzymatic route for chiral 3-amino-1-butanol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Novel synthesis route for chiral ligands reduces waste and cost. Reliable supply for asymmetric catalysis and pharmaceutical intermediate manufacturing processes.
Patent CN110627610B enables cost reduction in fine chemical manufacturing via copper-catalyzed asymmetric coupling. Secure high-purity chiral alkynes supply chain today.
Novel industrial synthesis of Adefovir dipivoxil ensures high purity and cost efficiency. Reliable supplier for pharmaceutical intermediates with scalable production capabilities.
Patent CN117510342A reveals improved 2,4-MDA selectivity via multi-step acid catalysis. Enhances supply chain stability and reduces manufacturing costs for global buyers.
Novel dual-acid catalyzed route for high-purity alpha-terpineol. Reduces cost and improves selectivity compared to traditional turpentine hydration methods.
Patent CN114989058B reveals a metal-free catalytic route for high-purity chiral chlorosulfoximines, offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Metal-free synthesis of alpha-thiocyanones using elemental sulfur. High yield, green process for reliable API intermediate supply chain.
Patent CN117069660A enables green benzimidazole synthesis using supercritical CO2. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
High-yield electrochemical method for phenanthridone intermediate. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN104892480B reveals green ionic liquid catalysis for high-purity intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107653238A reveals immobilized carbonyl reductase cells for high-yield statin intermediate production, offering significant supply chain stability and cost reduction advantages.
Patent CN106866425B reveals metal-free bromination. Achieve cost reduction in pharmaceutical intermediates manufacturing with high-purity scalable routes.
Patent CN103073443B details a novel asymmetric synthesis for Pregabalin, offering improved yield and scalability for pharmaceutical supply chains.
Advanced asymmetric synthesis of pregabalin via CN103073443B. Offers cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain solutions.
Patent CN103224501B details a high-yield artemisinin synthesis route. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains.
Patent CN106674300A reveals a novel Pd/Ni-catalyzed route for salidroside. Achieve high yields and cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Novel synthesis method for Pterostilbene phosphate disodium salt. High yield, mild conditions, scalable production for pharmaceutical applications.
Patent CN108912161B reveals a non-toxic Mg-Li bimetallic catalyst for cyanohydrin synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced L-proline catalyzed method offers neutral conditions and significant cost reduction in fine chemical intermediates manufacturing for global supply chains ensuring reliability.